Suppression of cell-mediated tumour immunity by Corynebacterium parvum
Suppression of cell-mediated tumour immunity by Corynebacterium parvum
复制标题
DOI:
10.1038/257396a0
复制
发表时间:
1975-10
期刊:
影响因子:
64.8
通讯作者:
H. Kirchner;M. Glaser;R. Herberman
中科院分区:
文献类型:
--
作者:
H. Kirchner;M. Glaser;R. Herberman
THE use of immunoadjuvants in tumour therapy is based largely on the concept that an increased level of specific immunity against tumour-associated antigens may be achieved by nonspecific stimulation of the immune system (for review see ref. 1). Among these adjuvants,Corynebacterium parvumhas received much attention since it represents one of the most powerful stimulants of the reticuloendothelial system in mice2, and is effective in inhibiting tumour growth in several animal tumour systems (for example, see refs 3–6). The mechanisms by whichC. parvuminterferes with tumour growth have not been established and the tumour protective effect ofC. parvumhas not been entirely consistent in all systems studied. An immunosuppressive effect ofC. parvumhas been demonstrated too. In mice, thein vitrolymphoproliferative responses to mitogens and to alloantigens were depressed after injection ofC. parvum. It remains to be determined, however, whether a defect measured by these general tests of T lymphocytes may also represent an indication of depressed cell-mediated immunity against tumour cells.